Affiliation:
1. Astrakhan State Medical University
2. Alexander-Mariinsky Regional Clinical Hospital
Abstract
The aim of the research. To study levels of the apoptosis biomarkers annexin A5 (AnxA5) and Bcl‑2 and to identify the presence of correlations of structural and functional parameters of the myocardium with the level of the studied biomarkers in patients with ischemic cardiomyopathy (ICMP).Materials and methods. Patients with ICMP (n = 47) were examined as the main group. The control group included 30 somatically healthy individuals. Bcl‑2 and APA5 levels were determined in the blood serum by the enzyme immunoassay.Results. It was found that in the group of patients with ICMP. The level of AnxA5 was statistically significantly higher (p < 0.001), and the level of Bcl‑2 was statistically significantly lower (p < 0.001) than in the control group. Based on the results of the correlation analysis a noticeable close relationship on the Cheddock scale was revealed between levels of the studied apoptosis biomarkers and the values of the sphericity index of in diastole and systole of left ventricle (LV), final diastolic and systolic volume of LV and ejection fraction of LV. Between the other parameters of myocardial remodeling and levels of the studied biomarkers of apoptosis, the closeness of relationships on the Cheddock scale were weak and moderate.
Subject
Materials Chemistry,Economics and Econometrics,Media Technology,Forestry
Reference13 articles.
1. Shipulin V. V., Saushkin V. V., Pryakhin A. S., Andreev S. L., Vesnina Zh.V., Zavadovsky K. V. Possibilities of myocardial perfusion scintigraphy in the examination of patients with ischemic cardiomyopathy. REJR. 2019; 9 (3): 155–175. https://doi.org/10.21569/2222–7415–2019–9–3–155–175
2. Dubovik T. A., Rachok L. V. Influence of hypoxytherapy on the course of chronic heart failure in patients with ischemic cardiomyopathy. Eurasian Cardiology Journal. 2017; 3: 32.
3. Shipulin V. M., Pryakhin A. S., Andreev S. L., Shipulin V. V., Kozlov B. N. Current state of the problem of surgical treatment of ischemic cardiomyopathy. Cardiology. 2019; 59 (9): 71–82. https://doi.org/10.18087//cardio.2019.9.n329
4. Shipulin V. V., Mishkina A. I., Gulya M. O., Varlamova Yu.V., Andreev S. L., Pryakhin A. S., Shipulin V. M., Zavadovsky K. V. Long-term prognosis of re-remodeling of the left ventricle after surgical treatment of ischemic cardiomyopathy: the possibilities of loading radionuclide tomoventriculography. Russian journal of cardiology. 2020; 11: 66–72. https://doi.org/10.15829/1560–4071–2020–3831
5. Myasoedova E. I. Myocardial fibrosis fraction and structural remodeling of the left heart in patients with ischemic cardiomyopathy. Astrakhan Medical Journal. 2017; 12 (2): 98–103.